IRENE RICHARD

Summary

Affiliation: University of Rochester
Country: USA

Publications

  1. pmc The patients' perspective: Results of a survey assessing knowledge about and attitudes toward depression in PD
    Irene Hegeman Richard
    University of Rochester School of Medicine and Dentistry, Rochester, NY, USA
    Neuropsychiatr Dis Treat 3:903-6. 2007
  2. pmc A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease
    I H Richard
    University of Rochester, Rochester, NY, USA
    Neurology 78:1229-36. 2012
  3. ncbi request reprint The ups and downs of Parkinson disease: a prospective study of mood and anxiety fluctuations
    Irene H Richard
    University of Rochester, Rochester, New York, USA
    Cogn Behav Neurol 17:201-7. 2004
  4. ncbi request reprint Depression and apathy in Parkinson's disease
    Irene Hegeman Richard
    Department of Neurology, University of Rochester School of Medicine, Mt Hope Professional Building, 1351 Mt Hope Avenue, Suite 100, Rochester, NY 14620 3917, USA
    Curr Neurol Neurosci Rep 7:295-301. 2007
  5. ncbi request reprint Risk factors for somnolence, edema, and hallucinations in early Parkinson disease
    Kevin M Biglan
    University of Rochester, Department of Neurology, Rochester, NY 14620, USA
    Neurology 69:187-95. 2007
  6. ncbi request reprint Anxiety disorders in Parkinson's disease
    Irene H Richard
    University of Rochester School of Medicine and Dentistry Rochester, New York, USA
    Adv Neurol 96:42-55. 2005
  7. ncbi request reprint Apathy does not equal depression in Parkinson disease: why we should care
    Irene Hegeman Richard
    Neurology 67:10-1. 2006
  8. ncbi request reprint A reality test: How well do we understand psychosis in Parkinson's disease?
    M Saleem Ismail
    Department of Psychiatry, University of Rochester, Medical Center, New York, USA
    J Neuropsychiatry Clin Neurosci 16:8-18. 2004
  9. ncbi request reprint Worsening of motor function and mood in a patient with Parkinson's disease after pharmacologic challenge with oral rivastigmine
    Irene Hegeman Richard
    Department of Neurology, University of Rochester School of Medicine and Dentistry, New York 14642, USA
    Clin Neuropharmacol 25:296-9. 2002
  10. ncbi request reprint Parkinson's disease and dementia with Lewy bodies: one disease or two?
    Irene Hegeman Richard
    University of Rochester School of Medicine and Dentistry, Department of Neurology, Rochester, New York 14642, USA
    Mov Disord 17:1161-5. 2002

Research Grants

Detail Information

Publications13

  1. pmc The patients' perspective: Results of a survey assessing knowledge about and attitudes toward depression in PD
    Irene Hegeman Richard
    University of Rochester School of Medicine and Dentistry, Rochester, NY, USA
    Neuropsychiatr Dis Treat 3:903-6. 2007
    ....
  2. pmc A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease
    I H Richard
    University of Rochester, Rochester, NY, USA
    Neurology 78:1229-36. 2012
    ..To evaluate the efficacy and safety of a selective serotonin reuptake inhibitor (SSRI) and a serotonin and norepinephrine reuptake inhibitor (SNRI) in the treatment of depression in Parkinson disease (PD)...
  3. ncbi request reprint The ups and downs of Parkinson disease: a prospective study of mood and anxiety fluctuations
    Irene H Richard
    University of Rochester, Rochester, New York, USA
    Cogn Behav Neurol 17:201-7. 2004
    ..Parkinson disease (PD) patients with motor fluctuations experience mood fluctuations, but studies have been limited in number and methodology...
  4. ncbi request reprint Depression and apathy in Parkinson's disease
    Irene Hegeman Richard
    Department of Neurology, University of Rochester School of Medicine, Mt Hope Professional Building, 1351 Mt Hope Avenue, Suite 100, Rochester, NY 14620 3917, USA
    Curr Neurol Neurosci Rep 7:295-301. 2007
    ..Although we are making strides toward a better understanding of depression and apathy in PD, it is clear that more research is needed about these non-motor features...
  5. ncbi request reprint Risk factors for somnolence, edema, and hallucinations in early Parkinson disease
    Kevin M Biglan
    University of Rochester, Department of Neurology, Rochester, NY 14620, USA
    Neurology 69:187-95. 2007
    ..A secondary finding of the trial was a higher than anticipated development or worsening of somnolence and edema and development of hallucinations...
  6. ncbi request reprint Anxiety disorders in Parkinson's disease
    Irene H Richard
    University of Rochester School of Medicine and Dentistry Rochester, New York, USA
    Adv Neurol 96:42-55. 2005
    ..The optimal pharmacologic treatment for anxiety in patients with PD has not been established, nor has the effect of PD surgery on anxiety symptoms...
  7. ncbi request reprint Apathy does not equal depression in Parkinson disease: why we should care
    Irene Hegeman Richard
    Neurology 67:10-1. 2006
  8. ncbi request reprint A reality test: How well do we understand psychosis in Parkinson's disease?
    M Saleem Ismail
    Department of Psychiatry, University of Rochester, Medical Center, New York, USA
    J Neuropsychiatry Clin Neurosci 16:8-18. 2004
    ..They also identify limitations in our understanding of this complex phenomenon and conclude that, despite availability of reasonable treatments for psychosis in PD, the search for a better understanding of the phenomenon must continue...
  9. ncbi request reprint Worsening of motor function and mood in a patient with Parkinson's disease after pharmacologic challenge with oral rivastigmine
    Irene Hegeman Richard
    Department of Neurology, University of Rochester School of Medicine and Dentistry, New York 14642, USA
    Clin Neuropharmacol 25:296-9. 2002
    ..We conclude that further studies should be done to evaluate the efficacy and tolerability of these agents in this illness but that caution should be exercised when using acetylcholinesterase inhibitors in patients with PD...
  10. ncbi request reprint Parkinson's disease and dementia with Lewy bodies: one disease or two?
    Irene Hegeman Richard
    University of Rochester School of Medicine and Dentistry, Department of Neurology, Rochester, New York 14642, USA
    Mov Disord 17:1161-5. 2002
    ..The mechanisms responsible for the different clinical presentations are not known, and the issue of whether PD and DLB represent two distinct diseases remains unsettled...
  11. ncbi request reprint Can "blue" genes affect mood and movement?
    Irene Hegeman Richard
    Neurology 63:610-1. 2004

Research Grants6

  1. Study of Antidepressants in Parkinson's Disease (SAD PD)
    IRENE RICHARD; Fiscal Year: 2007
    ..The trial will clarify many important questions regarding the treatment of depression in patients with PD. ..
  2. Serotonergic Antidepressant in Parkinson's Disease
    IRENE RICHARD; Fiscal Year: 2002
    ..The planning grant will set the stage for the clinical trial that will clarify many important questions regarding the optimal pharmacotherapy of depression in patients with PD. ..
  3. Study of Antidepressants in Parkinson's Disease (SAD PD)
    IRENE RICHARD; Fiscal Year: 2004
    ..The trial will clarify many important questions regarding the treatment of depression in patients with PD. ..
  4. MOOD FLUCTUATIONS IN PARKINSON'S DISEASE
    IRENE RICHARD; Fiscal Year: 2004
    ..It may also provide a better understanding of the mechanisms responsible for more pervasive forms of depression in PD, and perhaps even in primary psychiatric mood disturbances. ..
  5. Study of Antidepressants in Parkinson's Disease (SAD PD)
    IRENE RICHARD; Fiscal Year: 2005
    ..The trial will clarify many important questions regarding the treatment of depression in patients with PD. ..